Literature DB >> 20220154

Novel light-upon-extension real-time PCR assay for simultaneous detection, quantification, and genogrouping of group A rotavirus.

Johan Nordgren1, Filemón Bucardo, Lennart Svensson, Per-Eric Lindgren.   

Abstract

We have developed a light-upon-extension (LUX) real-time PCR assay for detection, quantification, and genogrouping of group A rotavirus (RV), the most common cause of acute gastroenteritis in children. The LUX system uses a fluorophore attached to one primer and having a self-quenching hairpin structure, making it cost-effective and specific. We designed genogroup-specific primers having different fluorophores, making it possible to differentiate between the two main genogroups of human group A RVs. The assay was applied on clinical stool specimens from Sweden and Central America (n=196) and compared to immunological and conventional PCR assays. The genogrouping ability was further validated against a subset of clinical specimens, which had been genogrouped using monoclonal antibodies. Our real-time PCR assay detected and quantified all positive specimens (n=145) and exhibited higher sensitivity than immunological assays and conventional PCR. The assay exhibited a wide dynamic range, detecting from 5 to >10(7) genes per PCR, resulting in a theoretical lower detection limit of <10,000 viruses per gram of stool. No cross-reaction was observed with specimens containing norovirus, sapovirus, astrovirus, or adenovirus. In total, 22 (15%) of the positive clinical specimens were identified as genogroup I, 122 (84%) were identified as genogroup II, and 1 specimen was found to contain a mix of both genogroups. All genogroup I-positive specimens were associated with capsid glycoprotein 2 (G2). No significant difference in viral load was found between genogroups or geographic region. The detection and quantification, combined with the genogrouping ability, make this assay a valuable tool both for diagnostics and for molecular epidemiological investigations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20220154      PMCID: PMC2863900          DOI: 10.1128/JCM.02288-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Reassortment in vivo: driving force for diversity of human rotavirus strains isolated in the United Kingdom between 1995 and 1999.

Authors:  M Iturriza-Gómara; B Isherwood; U Desselberger; J Gray
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore.

Authors:  Irina Nazarenko; Brian Lowe; Marlene Darfler; Pranvera Ikonomi; David Schuster; Ayoub Rashtchian
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

3.  Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype.

Authors:  M I Gómara; D Cubitt; U Desselberger; J Gray
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

4.  Quantitation of gene expression in neural precursors by reverse-transcription polymerase chain reaction using self-quenched, fluorogenic primers.

Authors:  Brian Lowe; Herbert A Avila; Fredric R Bloom; Martin Gleeson; Wolfgang Kusser
Journal:  Anal Biochem       Date:  2003-04-01       Impact factor: 3.365

5.  Molecular characterization of VP6 genes of human rotavirus isolates: correlation of genogroups with subgroups and evidence of independent segregation.

Authors:  Miren Iturriza Gómara; Cecilia Wong; Sandra Blome; Ulrich Desselberger; Jim Gray
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Detection and quantitation of group A rotaviruses by competitive and real-time reverse transcription-polymerase chain reaction.

Authors:  Bernd-Andreas Schwarz; Reinhard Bange; Thomas W Vahlenkamp; Reimar Johne; Hermann Müller
Journal:  J Virol Methods       Date:  2002-09       Impact factor: 2.014

Review 7.  Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses.

Authors:  R L Atmar; M K Estes
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

8.  Diversity of human rotavirus VP6, VP7, and VP4 in Lagos State, Nigeria.

Authors:  Rosemary Audu; S Aremu Omilabu; Mariet de Beer; Ina Peenze; A Duncan Steele
Journal:  J Health Popul Nutr       Date:  2002-03       Impact factor: 2.000

9.  Diagnosing rotavirus A associated IID: Using ELISA to identify a cut-off for real time RT-PCR.

Authors:  Gemma Phillips; Ben Lopman; Clarence C Tam; Miren Iturriza-Gomara; David Brown; Jim Gray
Journal:  J Clin Virol       Date:  2009-01-29       Impact factor: 3.168

Review 10.  Estimated mortality and hospital admission due to rotavirus infection in the WHO European region.

Authors:  C J Williams; A Lobanov; R G Pebody
Journal:  Epidemiol Infect       Date:  2009-01-12       Impact factor: 2.451

View more
  12 in total

1.  Bioluminescent enzyme immunoassay for the detection of norovirus capsid antigen.

Authors:  Nozomi Sakamaki; Yoshiyuki Ohiro; Mitsuki Ito; Mitsuru Makinodan; Tsubasa Ohta; Wataru Suzuki; Susumu Takayasu; Harufumi Tsuge
Journal:  Clin Vaccine Immunol       Date:  2012-10-17

Review 2.  Molecular detection and genotyping of noroviruses.

Authors:  Ambroos Stals; Elisabeth Mathijs; Leen Baert; Nadine Botteldoorn; Sarah Denayer; Axel Mauroy; Alexandra Scipioni; Georges Daube; Katelijne Dierick; Lieve Herman; Els Van Coillie; Etienne Thiry; Mieke Uyttendaele
Journal:  Food Environ Virol       Date:  2012-11-04       Impact factor: 2.778

3.  Sensitive and specific quantitative detection of rotavirus A by one-step real-time reverse transcription-PCR assay without antecedent double-stranded-RNA denaturation.

Authors:  Slavica Mijatovic-Rustempasic; Ka Ian Tam; Tara K Kerin; Jamie M Lewis; Rashi Gautam; Osbourne Quaye; Jon R Gentsch; Michael D Bowen
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948

4.  Development of a Real-Time Reverse Transcription-PCR Assay To Detect and Quantify Group A Rotavirus Equine-Like G3 Strains.

Authors:  Eric M Katz; Mathew D Esona; Rashi Gautam; Michael D Bowen
Journal:  J Clin Microbiol       Date:  2021-08-25       Impact factor: 5.948

Review 5.  Detection and evaluation of rotavirus surveillance methods as viral indicator in the aquatic environments.

Authors:  Paymaneh Atabakhsh; Mohammad Kargar; Abbas Doosti
Journal:  Braz J Microbiol       Date:  2021-02-18       Impact factor: 2.476

6.  Low prevalence of rotavirus and high prevalence of norovirus in hospital and community wastewater after introduction of rotavirus vaccine in Nicaragua.

Authors:  Filemón Bucardo; Per-Eric Lindgren; Lennart Svensson; Johan Nordgren
Journal:  PLoS One       Date:  2011-10-07       Impact factor: 3.240

7.  Emergence of unusual G6P[6] rotaviruses in children, Burkina Faso, 2009-2010.

Authors:  Johan Nordgren; Leon W Nitiema; Sumit Sharma; Djeneba Ouermi; Alfred S Traore; Jacques Simpore; Lennart Svensson
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

8.  Ionizing air affects influenza virus infectivity and prevents airborne-transmission.

Authors:  Marie Hagbom; Johan Nordgren; Rolf Nybom; Kjell-Olof Hedlund; Hans Wigzell; Lennart Svensson
Journal:  Sci Rep       Date:  2015-06-23       Impact factor: 4.379

9.  Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis.

Authors:  Jacqueline E Tate; Slavica Mijatovic-Rustempasic; Ka Ian Tam; Freda C Lyde; Daniel C Payne; Peter Szilagyi; Kathryn Edwards; Mary Allen Staat; Geoffrey A Weinberg; Caroline B Hall; James Chappell; Monica McNeal; Jon R Gentsch; Michael D Bowen; Umesh D Parashar
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

10.  One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix® and RotaTeq®) in stool samples.

Authors:  Rashi Gautam; Slavica Mijatovic-Rustempasic; Mathew D Esona; Ka Ian Tam; Osbourne Quaye; Michael D Bowen
Journal:  PeerJ       Date:  2016-01-11       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.